Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 8Breast Neoplasms 8Vitamin D Deficiency 7Polycystic Ovary Syndrome 4Leukemia, Lymphocytic, Chronic, B-Cell 3Warts 2Rectal Neoplasms 2Osteoporosis 2Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Stroke 1Spinal Cord Injuries 1Seizures 1Psoriasis 1Prostate Adenocarcinoma 1Polyps 1Pathologic Processes 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Obesity 1Neoplasms by Site 1Myelodysplastic Syndromes 1Meningitis 1Melanoma, Cutaneous Malignant 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

bosutinib 1Imatinib Mesylate 1Cholecalciferol 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pathologic Processes × Cholecalciferol × Clear all
NCT01166763 2016-07-18

Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D

University of Kansas Medical Center

Phase NA Completed
30 enrolled 10 charts
Breast

Breast Diseases, Breast Neoplasms, Hyperplasia, Neoplasms, Neoplasms by Site, Pathologic Processes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡